B
Bernard Fisher
Researcher at University of Pittsburgh
Publications - 379
Citations - 70162
Bernard Fisher is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 108, co-authored 377 publications receiving 67479 citations. Previous affiliations of Bernard Fisher include University of Texas Health Science Center at San Antonio & Mercy Medical Center (Baltimore, Maryland).
Papers
More filters
Journal ArticleDOI
Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure
TL;DR: It is concluded that nodal category, germinal center predominance, histologic grade, and tumor size represent strong prognostic discriminants exerting a rather constant influence on disease‐free survival at least to the tenth postmastectomy period.
Journal ArticleDOI
Detection and significance of occult axillary node metastases in patients with invasive breast cancer
TL;DR: It is concluded that attempts to detect occult metastases by extending histopathological methods may be more academic than practical or therapeutically significant.
Journal ArticleDOI
Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project.
TL;DR: The report indicates that the incidence of IBTR observed in the B-06 trial is decreased by effective systemic therapy as well, and findings that indicate the propriety of lumpectomy and breast irradiation for treatment of localized ductal carcinoma in situ are noted.
Journal ArticleDOI
The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings
TL;DR: There has arisen an altered concept of cancer biology during the past two decades and the National Surgical Adjuvant Project for Breast and Bowel Cancers has made a major contribution to the change through findings from a series of prospective randomized clinical trials.
Journal ArticleDOI
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
Richard Gray,Rosie Bradley,Jeremy P Braybrooke,Z Liu,Richard Peto,Lucy Davies,David Dodwell,Paul McGale,Hongchao Pan,Carolyn W. Taylor,William E. Barlow,Judith M Bliss,Paolo Bruzzi,David Cameron,George Fountzilas,Sibylle Loibl,John R. Mackey,Miguel Martín,Lucia Del Mastro,Volker Möbus,Valentina Nekljudova,Sabino De Placido,Sandra M. Swain,Michael Untch,Kathleen I. Pritchard,Jonas Bergh,Larry Norton,Clare Boddington,Julie Ann Burrett,Mike Clarke,C Davies,Fran Duane,Vaughan Evans,Lucy Gettins,Jon Godwin,Robert Kerrin Hills,Sam James,Hui Liu,Elizabeth MacKinnon,Gurdeep S. Mannu,Theresa McHugh,Philip Morris,Simon Read,Yaochen Wang,Zhe Wang,Peter A. Fasching,Nadia Harbeck,Pascal Piedbois,Michael Gnant,Guenther G. Steger,Angelo Di Leo,Stella Dolci,Prue Francis,Denis Larsimont,Jean Marie Nogaret,Catherine Philippson,Martine Piccart,Sabine C. Linn,Petronella Peer,Vivianne C. G. Tjan-Heijnen,Sonja Vliek,Dennis J. Slamon,John D. Bartlett,Vivien H.C. Bramwell,Bingshu E. Chen,Stephen Chia,Karen A. Gelmon,Paul E. Goss,Mark Levine,Wendy R. Parulekar,Joseph L. Pater,Eileen Rakovitch,Lois E. Shepherd,Dongsheng Tu,Timothy J. Whelan,Donald A. Berry,Gloria Broadwater,Constance Cirrincione,Hyman B. Muss,Raymond B. Weiss,Yi Shan,Yong Fu Shao,Xiang Wang,Binghe Xu,Dong-Bing Zhao,Harry Bartelink,Nina Bijker,Jan Bogaerts,Fatima Cardoso,Tanja Cufer,J.P. Julien,Philip Poortmans,Emiel J. Th. Rutgers,Cornelis J.H. van de Velde,Eva Carrasco,Miguel Angel Segui,Jens Uwe Blohmer,Serban Costa,Bernd Gerber,Christian Jackisch,Gunter von Minckwitz,Mario Giuliano,Michele De Laurentiis,Christina Bamia,Georgia-Angeliki Koliou,Dimitris Mavroudis,Roger A'Hern,Paul Ellis,Lucy Kilburn,James P Morden,John Yarnold,Mohammad Sadoon,Augustinus H Tulusan,Stewart J. Anderson,Gordon Bass,J. Costantino,James J. Dignam,Bernard Fisher,Charles E. Geyer,Eleftherios P. Mamounas,Soon Paik,Carol Redmond,D. Lawrence Wickerham,M. Venturini,Claudia Bighin,Simona Pastorino,Paolo Pronzato,Mario Roberto Sertoli,Theodorus Foukakis,Kathy S. Albain,Rodrigo Arriagada,Elizabeth Bergsten Nordström,Francesco Boccardo,Etienne Brain,Lisa A. Carey,Alan S. Coates,Robert E. Coleman,C Correa,Jack Cuzick,Nancy E. Davidson,Mitch Dowsett,Marianne Ewertz,John F. Forbes,Richard D. Gelber,Aron Goldhirsch,Pamela J. Goodwin,Daniel F. Hayes,Christopher Hill,James N. Ingle,Reshma Jagsi,Wolfgang Janni,Hirofumi Mukai,Yasuo Ohashi,Lori J. Pierce,Vinod Raina,Peter M. Ravdin,Daniel Rea,Meredith M. Regan,John F.R. Robertson,Joseph A. Sparano,Andrew Tutt,Giuseppe Viale,Nicholas Wilcken,Norman Wolmark,Wiliam Wood,Milvia Zambetti +165 more
TL;DR: Increasing the dose intensity of adjuvant chemotherapy by shortening the interval between treatment cycles, or by giving individual drugs sequentially rather than giving the same drugs concurrently, moderately reduces the 10-year risk of recurrence and death from breast cancer without increasing mortality from other causes.